172 related articles for article (PubMed ID: 26018318)
1. Twist promotes invasion and cisplatin resistance in pancreatic cancer cells through growth differentiation factor 15.
Ji H; Lu HW; Li YM; Lu L; Wang JL; Zhang YF; Shang H
Mol Med Rep; 2015 Sep; 12(3):3841-3848. PubMed ID: 26018318
[TBL] [Abstract][Full Text] [Related]
2. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
Peng F; Zhang H; Du Y; Tan P
Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells.
Tsui KH; Chang YL; Feng TH; Chung LC; Lee TY; Chang PL; Juang HH
J Mol Endocrinol; 2012 Oct; 49(2):153-63. PubMed ID: 22872134
[TBL] [Abstract][Full Text] [Related]
4. Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway.
Zhuo WL; Wang Y; Zhuo XL; Zhang YS; Chen ZT
Biochem Biophys Res Commun; 2008 May; 369(4):1098-102. PubMed ID: 18331824
[TBL] [Abstract][Full Text] [Related]
5. Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through β-catenin signaling.
Zheng L; Li N; Guo F; Jian XC; Jiang CH; Yin P; Min AJ; Huang L
Mol Med Rep; 2015 Mar; 11(3):2255-61. PubMed ID: 25378227
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion.
Griner SE; Joshi JP; Nahta R
Biochem Pharmacol; 2013 Jan; 85(1):46-58. PubMed ID: 23085437
[TBL] [Abstract][Full Text] [Related]
7. GDF15 promotes epithelial-to-mesenchymal transition in colorectal [corrected].
Zhang Y; Wang X; Zhang M; Zhang Z; Jiang L; Li L
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):652-658. PubMed ID: 29771147
[TBL] [Abstract][Full Text] [Related]
8. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
9. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
10. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis.
Meier JC; Haendler B; Seidel H; Groth P; Adams R; Ziegelbauer K; Kreft B; Beckmann G; Sommer A; Kopitz C
Cancer Med; 2015 Feb; 4(2):253-67. PubMed ID: 25490861
[TBL] [Abstract][Full Text] [Related]
12. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling.
Huang Z; Huang Y; He H; Ni J
Mol Med Rep; 2015 Sep; 12(3):3916-3922. PubMed ID: 26017117
[TBL] [Abstract][Full Text] [Related]
13. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.
Cheng GZ; Chan J; Wang Q; Zhang W; Sun CD; Wang LH
Cancer Res; 2007 Mar; 67(5):1979-87. PubMed ID: 17332325
[TBL] [Abstract][Full Text] [Related]
14. NS-398 promotes pancreatic cancer cell invasion by CD147 and MMP-2 via the activation of P38.
Liu H; Xu XF; Zhao Y; Tang MC; Zhou YQ; Gao FH
Mol Med Rep; 2016 Mar; 13(3):2208-14. PubMed ID: 26782265
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells.
Wang J; Li L; Wu K; Ge W; Zhang Z; Gong L; Yuan D
Pharmazie; 2016 Oct; 71(10):598-602. PubMed ID: 29441929
[TBL] [Abstract][Full Text] [Related]
16. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.
Zhang L; Yang X; Li X; Li C; Zhao L; Zhou Y; Hou H
Int J Mol Med; 2015 Oct; 36(4):957-66. PubMed ID: 26310353
[TBL] [Abstract][Full Text] [Related]
17. Twist promotes tumor cell growth through YB-1 expression.
Shiota M; Izumi H; Onitsuka T; Miyamoto N; Kashiwagi E; Kidani A; Yokomizo A; Naito S; Kohno K
Cancer Res; 2008 Jan; 68(1):98-105. PubMed ID: 18172301
[TBL] [Abstract][Full Text] [Related]
18. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
19. Qizhen capsule inhibits colorectal cancer by inducing NAG-1/GDF15 expression that mediated via MAPK/ERK activation.
Guo D; Guo C; Fang L; Sang T; Wang Y; Wu K; Guo C; Wang Y; Pan H; Chen R; Wang X
J Ethnopharmacol; 2021 Jun; 273():113964. PubMed ID: 33640439
[TBL] [Abstract][Full Text] [Related]
20. Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.
Chen SH; Hung WC; Wang P; Paul C; Konstantopoulos K
Sci Rep; 2013; 3():1870. PubMed ID: 23694968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
